Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Short Interest Down 15.4% in February

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) was the target of a large decline in short interest in February. As of February 15th, there was short interest totalling 947,300 shares, a decline of 15.4% from the January 31st total of 1,120,000 shares. Based on an average daily volume of 1,060,000 shares, the days-to-cover ratio is currently 0.9 days.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Lake Street Capital dropped their price target on shares of Ekso Bionics from $2.00 to $1.00 and set a “buy” rating for the company in a research report on Tuesday. StockNews.com initiated coverage on Ekso Bionics in a report on Monday. They set a “hold” rating on the stock. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $9.00 price target on shares of Ekso Bionics in a research note on Tuesday.

Ekso Bionics Stock Up 0.4 %

Shares of EKSO opened at $0.48 on Wednesday. The firm has a 50 day simple moving average of $0.61 and a two-hundred day simple moving average of $0.82. The company has a market cap of $10.52 million, a P/E ratio of -0.74 and a beta of 1.46. Ekso Bionics has a one year low of $0.37 and a one year high of $1.78. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.81 and a quick ratio of 2.14.

Ekso Bionics (NASDAQ:EKSO) last released its quarterly earnings data on Monday, March 3rd. The company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.07). The business had revenue of $5.09 million during the quarter, compared to analyst estimates of $5.05 million. Ekso Bionics had a negative net margin of 62.95% and a negative return on equity of 83.09%. Research analysts forecast that Ekso Bionics will post -0.48 EPS for the current fiscal year.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.